August 24, 2016 4:12 AM ET

Biotechnology

Company Overview of Euroscreen S.A.

Executive Profile

Daniel F. Veber Ph.D.

Scientific Advisor, Euroscreen S.A.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Daniel F. Veber, Dan, Ph.D, serves as Medicinal Chemistry Advisor of Tranzyme Inc. Dr. Veber serves as an Independent Consultant to the Pharmaceutical Industry. He serves as Scientific Advisor of The Institute for OneWorld Health, Euroscreen S.A. He served as a Member of Scientific Advisory Board of Aileron Therapeutics Inc. From 1993 to 2002, he served as Director of Medicinal Chemistry for SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline). He was responsible ...

Corporate Headquarters

Route de Lennik 802
Brussels, Brussels 1070

Belgium

Phone: 32 2 529 00 11
Fax: 32 2 529 00 19

Board Members Memberships

There is no Board Members Memberships data available.

Education

MS 1962
Yale University
PhD 1964
Yale University
Bachelor's Degree
Yale University
BA 1961
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Euroscreen S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.